VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by mjh9413on Jul 31, 2019 3:24pm

273 Views

Post# 29980903

RE:RE:RE:here's the latest letter re: another new sale

Thanks. So they have to sell 17 plus machines to break even on their last qtr's oper costs (but including finance charges), on something like 85% margin. Costs always go up when prodn ramps up and sales, etc., are to the fore, so this looks a little like TSO3, particularly if distribution partnerships are broadened. I follow but I am going to have to see a couple of qtrs' results...

Bullboard Posts

Nord Precious Metals reveals silver zone at Castle East